Modified measles vaccine schedule to help prevent allergies in babies
Part of Immune system & allergy, Infections, Lungs & breathing, Skin clinical trials.
This study tests whether changing the measles vaccine timing in 6-month-old children can reduce allergy risk and also help protect against unrelated infections. If your child is already up to date with routine vaccines, they may be eligible for a modified measles (MMR) schedule used in the trial.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is 6 months old at the time of joining
- You can sign a consent form and agree to follow the study steps
- Your child is generally healthy with no serious ongoing health problems
- Your child is fully vaccinated for age under the Swiss schedule
- At least 2 doses of DTP-containing vaccine have been given, and the last dose was at least 2 weeks ago
- Your child has no reasons they should not receive MMR (measles vaccine)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combined booster vaccine for measles, mumps, rubella, and chickenpox in healthy children aged 4 to 6. It aims to see how well the vaccine boosts the immune system and if it is safe.
This study tests a combined vaccine that protects against measles, mumps, rubella, and chickenpox (varicella) in one shot. It's for healthy children who have already had their first dose of chickenpox and MMR vaccines, to see if this booster is safe and works well.
This trial checks whether giving the measles-rubella (MR) and yellow fever vaccines at the same time is safe and works well in healthy babies aged 9 to 12 months. It may help simplify the vaccination schedule.
This study looks at how the immune system responds to measles infection or vaccination in adults. It may help explain why some people develop stronger immunity than others.
This trial is testing whether giving the R21 malaria vaccine to infants at different ages (starting at 2 months or 3 months) works as well as starting at 6 weeks. It will help find the best schedule to protect babies against malaria.
This study looks at how measles affects children differently based on whether they have been vaccinated or had the infection before. It aims to understand why some children get very sick and others don't.
Hear when a new Respiratory Tract Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.